A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts
- PMID: 30247462
- PMCID: PMC6235117
- DOI: 10.3791/57231
A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts
Abstract
Vein graft bypass surgery is a common treatment for occlusive arterial disease; however, long-term success is limited by graft failure due to thrombosis, intimal hyperplasia, and atherosclerosis. The goal of this article is to demonstrate a method for placing bilateral venous interposition grafts in a rabbit, then transducing the grafts with a gene transfer vector that achieves durable transgene expression. The method allows the investigation of the biological roles of genes and their protein products in normal vein graft homeostasis. It also allows the testing of transgenes for the activities that could prevent vein graft failure, e.g., whether the expression of a transgene prevents the neointimal growth, reduces the vascular inflammation, or reduces atherosclerosis in rabbits fed with a high-fat diet. During an initial survival surgery, the segments of right and left external jugular vein are excised and placed bilaterally as reversed end-to-side common carotid artery interposition grafts. During a second survival surgery, performed 28 days later, each of the grafts is isolated from the circulation with vascular clips and the lumens are filled (via an arteriotomy) with a solution containing a helper-dependent adenoviral (HDAd) vector. After a 20-min incubation, the vector solution is aspirated, the arteriotomy is repaired, and flow is restored. The veins are harvested at time points dictated by individual experimental protocols. The 28-day delay between the graft placement and the transduction is necessary to ensure the adaptation of the vein graft to the arterial circulation. This adaptation avoids rapid loss of transgene expression that occurs in vein grafts transduced before or immediately after grafting. The method is unique in its ability to achieve durable, stable transgene expression in grafted veins. Compared to other large animal vein graft models, rabbits have advantages of low cost and easy handling. Compared to rodent vein graft models, rabbits have larger and easier-to-manipulate blood vessels that provide abundant tissue for analysis.
Similar articles
-
Efficient gene transfer and durable transgene expression in grafted rabbit veins.Hum Gene Ther. 2015 Jan;26(1):47-58. doi: 10.1089/hum.2014.084. Hum Gene Ther. 2015. PMID: 25383597 Free PMC article.
-
Adenoviral-mediated expression of antisense RNA to basic fibroblast growth factor reduces tangential stress in arterialized vein grafts.J Vasc Surg. 2000 Apr;31(4):770-80. doi: 10.1067/mva.2000.103239. J Vasc Surg. 2000. PMID: 10753285
-
Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.J Vasc Surg. 2011 Dec;54(6):1753-9. doi: 10.1016/j.jvs.2011.06.081. Epub 2011 Sep 3. J Vasc Surg. 2011. PMID: 21890304
-
Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies.Circ J. 2010 Aug;74(8):1501-12. doi: 10.1253/circj.cj-10-0495. Epub 2010 Jul 1. Circ J. 2010. PMID: 20606326 Free PMC article. Review.
-
Gene therapy for the prevention of vein graft disease.Transl Res. 2013 Apr;161(4):321-38. doi: 10.1016/j.trsl.2012.12.003. Epub 2012 Dec 27. Transl Res. 2013. PMID: 23274305 Free PMC article. Review.
Cited by
-
Response by Dichek to Letter Regarding Article, "Jugular Vein Injection of High-Titer Lentiviral Vectors Does Not Transduce the Aorta".Arterioscler Thromb Vasc Biol. 2021 Apr;41(4):e240-e242. doi: 10.1161/ATVBAHA.121.315965. Epub 2021 Mar 24. Arterioscler Thromb Vasc Biol. 2021. PMID: 33760630 Free PMC article. No abstract available.
-
Apolipoprotein A-I vascular gene therapy reduces vein-graft atherosclerosis.Mol Ther Methods Clin Dev. 2023 Aug 22;30:558-572. doi: 10.1016/j.omtm.2023.08.018. eCollection 2023 Sep 14. Mol Ther Methods Clin Dev. 2023. PMID: 37693942 Free PMC article.
References
-
- Fowkes FG, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–1340. - PubMed
-
- Mohr FW, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381:629–638. - PubMed
-
- de Vries MR, Simons KH, Jukema JW, Braun J, Quax PH. Vein graft failure: from pathophysiology to clinical outcomes. Nat Rev Cardiol. 2016;13(8):451–470. - PubMed
-
- Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013;257:824–833. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources